Bluejay Diagnostics (BJDX) Change in Inventory (2020 - 2022)
Bluejay Diagnostics recorded quarterly Change in Inventory of -$221924.0 in Q2 2022, down 124.85% quarter-over-quarter from $893174.0 in Q1 2022.
Bluejay Diagnostics' Change in Inventory history runs 2 years deep, the most recent figure standing at -$221924.0 for Q2 2022.
- In Q2 2022, Change in Inventory changed N/A year-over-year to -$221924.0; the TTM figure through Jun 2022 stood at $671250.0 (changed N/A YoY), while the FY2021 annual figure was -$84762.0, down 118.76% from the prior year.
- Change in Inventory came in at -$221924.0 for Q2 2022 at Bluejay Diagnostics, down from $893174.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $893174.0 in Q1 2022 to a low of -$221924.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 131.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -264.59 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 65.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -38.50 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -221,924.00 |
| Jun 30, 2022 | -221,924.00 |
| Mar 31, 2022 | 893,174.00 |
| Mar 31, 2022 | 893,174.00 |
| Dec 31, 2020 | -123,508.00 |
| Dec 31, 2020 | -123,508.00 |